These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12974272)

  • 1. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
    Castillo S; Ramaiah B; Blum S; Remy P
    Gastroenterology; 2003 Sep; 125(3):999; author reply 999-1000. PubMed ID: 12974272
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
    Joossens S; Reinisch W; Vermeire S; Sendid B; Poulain D; Peeters M; Geboes K; Bossuyt X; Vandewalle P; Oberhuber G; Vogelsang H; Rutgeerts P; Colombel JF
    Gastroenterology; 2002 May; 122(5):1242-7. PubMed ID: 11984510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Jury is out' on value of combination GI test panel.
    Ringel M
    CAP Today; 1998 Jun; 12(6):26-8, 32. PubMed ID: 10181171
    [No Abstract]   [Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of current clinical value of serological testing in the evaluation of patients with IBD.
    MacDermott RP
    Inflamm Bowel Dis; 1999 Feb; 5(1):64-5; discussion 66-7. PubMed ID: 10028451
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
    Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.
    Sura SP; Ahmed A; Cheifetz AS; Moss AC
    J Clin Gastroenterol; 2014 Apr; 48(4):351-5. PubMed ID: 24492405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of serologic studies in inflammatory bowel disease.
    Vernier G; Sendid B; Poulain D; Colombel JF
    Curr Gastroenterol Rep; 2004 Dec; 6(6):482-7. PubMed ID: 15527678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
    Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic markers in inflammatory bowel disease: state of the art.
    Sandborn WJ
    Rev Gastroenterol Disord; 2004; 4(4):167-74. PubMed ID: 15580151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ulcerative colitis and Crohn's disease].
    Matsuoka K; Hibi T
    Nihon Rinsho; 2005 May; 63 Suppl 5():507-11. PubMed ID: 15954400
    [No Abstract]   [Full Text] [Related]  

  • 15. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
    Papadakis KA; Targan SR
    Curr Gastroenterol Rep; 1999 Dec; 1(6):482-5. PubMed ID: 10980990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic testing for inflammatory bowel disease.
    Hoffenberg EJ; Fidanza S; Sauaia A
    J Pediatr; 1999 Apr; 134(4):447-52. PubMed ID: 10190919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indeterminate colitis.
    Geboes K; De Hertogh G
    Inflamm Bowel Dis; 2003 Sep; 9(5):324-31. PubMed ID: 14555917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
    Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.